Caroline E. Brun

Caroline E. Brun

Auto-generated profile, based on publicly available information

Caroline E. Brun

Institut NeuroMyoGène, Physiopathologie et Génétique du Neurone et du Muscle, UMR CNRS 5261 – INSERM U1315, Université Claude Bernard Lyon 1, Lyon, France

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Seminars in Cell & Developmental Biology
Verified
Journal Article
Open access
JHJose Manuel Hernandez
Jose Manuel Hernandez
EGEstela G. García-González
Estela G. García-González
CBCaroline E. Brun
Caroline E. Brun
MRMichael Rudnicki
Michael Rudnicki
The Myogenic Regulatory Factors (MRFs) Myf5, MyoD, myogenin and MRF4 are members of the basic helix-loop-helix family of transcription factors that control the determination and differentiation of skeletal muscle cells during embryogenesis and postnatal myogenesis. The dynamics of their temporal and spatial expression as well as their biochemical properties have allowed the identification of a precise and hierarchical relationship between the four MRFs. This relationship establishes the myogenic lineage as well as the maintenance of the terminal myogenic phenotype. The application of genome-wide technologies has provided important new information as to how the MRFs function to activate muscle gene expression. Application of combined functional genomics technologies along with single cell lineage tracing strategies will allow a deeper understanding of the mechanisms mediating myogenic determination, cell differentiation and muscle regeneration.

16 November 2015 in Nature Medicine
Verified
Journal Article
Open access
PDF file
NDNicolas A Dumont
Nicolas A Dumont
YWYu Xin Wang
Yu Xin Wang
JMJulia von Maltzahn
Julia von Maltzahn
APAlessandra Pasut
Alessandra Pasut
CBC Florian Bentzinger
C Florian Bentzinger
MRMichael Rudnicki
Michael Rudnicki
Dystrophin is expressed in muscle stem cells, in which it regulates their cell division and proper repopulation. Dystrophin is expressed in differentiated myofibers, in which it is required for sarcolemmal integrity, and loss-of-function mutations in the gene that encodes it result in Duchenne muscular dystrophy (DMD), a disease characterized by progressive and severe skeletal muscle degeneration. Here we found that dystrophin is also highly expressed in activated muscle stem cells (also known as satellite cells), in which it associates with the serine-threonine kinase Mark2 (also known as Par1b), an important regulator of cell polarity. In the absence of dystrophin, expression of Mark2 protein is downregulated, resulting in the inability to localize the cell polarity regulator Pard3 to the opposite side of the cell. Consequently, the number of asymmetric divisions is strikingly reduced in dystrophin-deficient satellite cells, which also display a loss of polarity, abnormal division patterns (including centrosome amplification), impaired mitotic spindle orientation and prolonged cell divisions. Altogether, these intrinsic defects strongly reduce the generation of myogenic progenitors that are needed for proper muscle regeneration. Therefore, we conclude that dystrophin has an essential role in the regulation of satellite cell polarity and asymmetric division. Our findings indicate that muscle wasting in DMD not only is caused by myofiber fragility, but also is exacerbated by impaired regeneration owing to intrinsic satellite cell dysfunction.

1 November 2018 in Cell Stem Cell
Verified
Journal Article
Closed access
PFPeter Feige
Peter Feige
CBCaroline E. Brun
Caroline E. Brun
MRMorten Ritso
Morten Ritso
MRMichael Rudnicki
Michael Rudnicki

1 May 2018 in Cell Stem Cell
Verified
Journal Article
Closed access
NCNatasha C. Chang
Natasha C. Chang
MSMarie-Claude Sincennes
Marie-Claude Sincennes
FCFabien Chevalier
Fabien Chevalier
CBCaroline E. Brun
Caroline E. Brun
MLMelanie Lacaria
Melanie Lacaria
MRMichael Rudnicki
Michael Rudnicki

1 March 2019 in Cell Stem Cell
Verified
Journal Article
Closed access
YWYu Xin Wang
Yu Xin Wang
PFPeter Feige
Peter Feige
CBCaroline E. Brun
Caroline E. Brun
BHBahareh Hekmatnejad
Bahareh Hekmatnejad
NDNicolas A. Dumont
Nicolas A. Dumont
MRMichael Rudnicki
Michael Rudnicki

21 January 2016 in Stem Cells Translational Medicine
Verified
Journal Article
Open access
PDF file
MSMarie-Claude Sincennes
Marie-Claude Sincennes
CBCaroline E. Brun
Caroline E. Brun
MRMichael Rudnicki
Michael Rudnicki
Skeletal muscle regeneration is initiated by satellite cells, a population of adult stem cells that reside in the muscle tissue. The ability of satellite cells to self-renew and to differentiate into the muscle lineage is under transcriptional and epigenetic control. Satellite cells are characterized by an open and permissive chromatin state. The transcription factor Pax7 is necessary for satellite cell function. Pax7 is a nodal factor regulating the expression of genes associated with satellite cell growth and proliferation, while preventing differentiation. Pax7 recruits chromatin modifiers to DNA to induce expression of specific target genes involved in myogenic commitment following asymmetric division of muscle stem cells. Emerging evidence suggests that replacement of canonical histones with histone variants is an important regulatory mechanism controlling the ability of satellite cells and myoblasts to differentiate. Differentiation into the muscle lineage is associated with a global gene repression characterized by a decrease in histone acetylation with an increase in repressive histone marks. However, genes important for differentiation are upregulated by the specific action of histone acetyltransferases and other chromatin modifiers, in combination with several transcription factors, including MyoD and Mef2. Treatment with histone deacetylase (HDAC) inhibitors enhances muscle regeneration and is considered as a therapeutic approach in the treatment of muscular dystrophy. This review describes the recent findings on epigenetic regulation in satellite stem cells and committed myoblasts. The potential of epigenetic drugs, such as HDAC inhibitors, as well as their molecular mechanism of action in muscle cells, will be addressed. Significance: This review summarizes recent findings concerning the epigenetic regulation of satellite cells in skeletal muscle.